More Options, More Hope: The New Reality for Newly Diagnosed Myeloma | Gurbakhash Kaur, MD #myeloma

The landscape for newly diagnosed multiple myeloma has changed dramatically. In this HealthTree Roundtable talk, Dr. Gurbakhash Kaur explains how new treatment options—including combinations with immunotherapies, CELMoDs, and targeted drugs—are creating more personalized and hopeful paths for patients. If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/6286... For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.

Can You Stop Myeloma Treatment and Still Stay in Remission?
▶︎

Can You Stop Myeloma Treatment and Still Stay in Remission?

The Modern Myeloma Toolbox | Tarek Mouhieddine, MD #myeloma
▶︎

The Modern Myeloma Toolbox | Tarek Mouhieddine, MD #myeloma

Most Relevant New Datasets and Advances in Chronic Lymphocytic Leukemia
▶︎

Most Relevant New Datasets and Advances in Chronic Lymphocytic Leukemia

Is Multiple Myeloma Fatal? What Experts Say About Living a Normal Life
▶︎

Is Multiple Myeloma Fatal? What Experts Say About Living a Normal Life

Exciting Clinical Trials for CLL in 2025
▶︎

Exciting Clinical Trials for CLL in 2025

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

From Breakthrough to Bedside: The CAR-T Story and UPenn's Legacy | Adam Cohen, MD #myeloma
▶︎

From Breakthrough to Bedside: The CAR-T Story and UPenn's Legacy | Adam Cohen, MD #myeloma

Myeloma Philadelphia HealthTree Round Table - Audience Q&A with Faculty
▶︎

Myeloma Philadelphia HealthTree Round Table - Audience Q&A with Faculty

Understanding Your Myeloma Labs: What They Mean, What Matters, and When to Ask Questions
▶︎

Understanding Your Myeloma Labs: What They Mean, What Matters, and When to Ask Questions

What are the barriers to research in the community oncology setting?
▶︎

What are the barriers to research in the community oncology setting?

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained
▶︎

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained

ESMO EBN Presentation Safety and Sustainability October 2025
▶︎

ESMO EBN Presentation Safety and Sustainability October 2025

Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
▶︎

Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Jean-Marie Michot, MD, Shares Olympia-3 Insights on Odronextamab Plus Chemotherapy in DLBCL
▶︎

Jean-Marie Michot, MD, Shares Olympia-3 Insights on Odronextamab Plus Chemotherapy in DLBCL

Expanding Myeloma Treatments: Power of Bispecific & Trispecific Antibodies| Dr. Aravind Ramakrishnan
▶︎

Expanding Myeloma Treatments: Power of Bispecific & Trispecific Antibodies| Dr. Aravind Ramakrishnan

New & Emerging Treatments for CLL - 2026
▶︎

New & Emerging Treatments for CLL - 2026

🔑 Unlock Your Healthcare Career: Info Session with CareerStep & Florida Training Academy
▶︎

🔑 Unlock Your Healthcare Career: Info Session with CareerStep & Florida Training Academy

Current Concepts in the Systemic Treatment of Thymoma | Dr Ross Soo
▶︎

Current Concepts in the Systemic Treatment of Thymoma | Dr Ross Soo

What Happens After CAR T-Cell Therapy? Myeloma Experts Answer Common Questions
▶︎

What Happens After CAR T-Cell Therapy? Myeloma Experts Answer Common Questions

Smoldering Myeloma: What We Know and Where We're Going
▶︎

Smoldering Myeloma: What We Know and Where We're Going